February 11, 2012
| Bio-IT World > Protein Chips Go Public


Protein Chips Go Public


By Malorye Branca

August 13, 2002 | It might be tough to tear some protein researchers away from their 2-D gels, but the majority would embrace protein chips if the technology was affordable, accessible, and offered the proteins that interest them.

Protein chips can be used to study a variety of processes, including protein-protein interactions, protein expression, and small-molecule protein binding. For example, Michael Snyder's group at Yale University has developed protein chips to enable analysis of virtually all 6,000 proteins in yeast.

Until recently, protein chips were produced by a handful of biotech companies, most of which had


High-throughput proteomics simplified with PerkinElmer's Protein Array Workstation.
 
their sights set on Big Pharma, or at least biotech, collaborators. Now, companies like BD Biosciences Clontech and PerkinElmer Life Sciences are aiming to change that.

BD Clontech is offering what may be the first off-the-shelf, antibody-based chips for protein expression profiling — the Ab Microarray. The chip contains 378 monoclonal antibodies immobilized onto a glass surface. Researchers can use the chips, which cost about $2,000 for two, to compare the range of proteins found in two samples.

Clontech won't be alone in this market for long. "You will start seeing more companies offering preprinted arrays, probably later this summer," says Robert Cavallo, product manager for PerkinElmer Life Science's Protein Microarrays. PerkinElmer is also developing protein chips, as well as other tools that should make it easier for the average scientist to get into the field. "We have made a big commitment to this area," says Cavallo.

In September, PerkinElmer will launch its Protein Array Workstation, which automates protein chip studies. It can accommodate two low-volume samples per slide, and carries out the required chemistries.

But handling proteins is a lot more difficult than dealing with DNA, Cavallo points out, and researchers will want to do more complex studies, such as "sandwich" assays that involve applying the sample to the chip, and then adding a detection antibody. "I think people will end up using both DNA chips and protein chips," Cavallo says. "You can get different information from each one."

—Malorye Branca 

Back to The Proteomics Odyssey 




White Papers & Special Reports

sgi whp 2
Managing the Modern Genomics Data Flood
Sponsored by SGI

Managing and storing the perfect storm of multi-disciplined data pouring from next generation sequencers and other omics instruments is a central challenge in life sciences. Discover in this paper how the SGI ArcFiniti storage solution, optimized for unstructured genomics and life sciences data can: 

  • Reduce costs, proactively protect data integrity, and deliver the high performance I/O required for genomics data processing and analysis.  
  • Effectively manage capacities from 156TB to 1.4PB as a disk based, integrated hardware and software platform 


sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 
Apply at http://jobs.tessella.com   

oxford nanopore logo 


Early Access Collaborations ManagersClick here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Click to  Apply  

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .